A human keratinocyte cDNA expression library in bacteriophage Agtll was screened with the purified IgG fraction ofserum from a patient with epidermolysis bullosa acquisita, which had a high titer of anti-type VII collagen antibodies. Screening of -3 x 105 plaques identified 8 positive clones, the largest one (K-131) being -1.9 kilobases in size. Dideoxynucleotide sequencing of K-131 indicated that it consisted of 1875 base pairs and contained an open reading frame coding for a putative N-terminal noncollagenous domain of 439 amino acids and a collagenous C-terminal segment of 186 amino acids. The collagenous domain was characterized by repeating Gly-Xaa-Yaa sequences that were interrupted in several positions by insertions or deletions of 1-3 amino acids. The deduced amino acid sequence also revealed a peptide segment that had a high degree of identity with a published type VII collagen protein sequence. Northern hybridization of the K-131 cDNA with human epidermal keratinocyte and skin fibroblast RNA revealed an mRNA of '=8.5 kilobases. The fusion protein produced by the K-131 cDNA, when incubated with epidermolysis bullosa acquisita serum, bound to antibodies that reacted in Western blots with type VII collagen. The genomic location of the type VII collagen gene (COL7AI) was determined by chromosomal in situ hybridization with the K-131 cDNA. The results mapped the COL7AI to the locus 3p2l. The cDNA clones characterized in this study will be valuable for understanding the protein structure and gene expression of type VII collagen present in anchoring fibrils and its aberrations in the dystrophic forms of heritable epidermolysis bullosa.
The collagens comprise a family of closely related, yet genetically distinct, macromolecules. At least 14 different vertebrate collagens have been identified. All collagen molecules consist of three subunit polypeptides, called a chains, and there are as many as 25 different genes within the human genome that code for these subunits (for review on collagens, see refs. [1] [2] [3] .
The genetically distinct collagens have characteristic tissue distributions. The more abundant collagens, as exemplified by types I and III collagens, have a rather widespread distribution, while some minor collagens have a limited anatomical location. For example, type VII collagen appears to be restricted to the basement membrane zone beneath stratified squamous epithelia. Within the cutaneous basement membrane zone, type VII collagen localizes to the lamina densa and sub-lamina densa areas in the upper papillary dermis (4, 5) . More precisely, immunolocalization studies have demonstrated that type VII collagen is the major collagenous component of anchoring fibrils, morphologically distinct structures that extend from the lamina densa and project perpendicularly into the upper papillary dermis (6, 7) .
Type VII collagen extracted from tissues has been suggested to consist ofa central collagenous domain of -145 kDa and a C-terminal noncollagenous domain (NC-1) of the same size (8, 9) . In addition, the biosynthetic precursor product, the proal(VII) chain, has been suggested to contain a smaller, -30-kDa N-terminal noncollagenous domain (NC-2) that is cleaved extracellularly (10) . The major tissue form of type VII collagen has been suggested to be an antiparallel dimer associated through an overlap region of the individual molecules at the N termini; this association is stabilized by disulfide bonds (11) . The antiparallel dimers aggregate laterally to form anchoring fibrils with characteristic banding recognized by transmission electron microscopy. In fact, it was the similarity of banding patterns in anchoring fibrils and in segment-long-spacing preparations of type VII collagen that led to the initial suggestion of their identity (12, 13) .
The primary sequences of many of the minor collagens have been deduced from cloned complementary and genomic DNAs. In the case of type VII collagen, only limited sequence information is available from protein analyses (9) . Previous attempts to isolate type VII collagen cDNAs have proven difficult apparently due to the low abundance of the corresponding mRNA transcripts. Here we report successful isolation of human cDNAs that correspond to type VII collagen sequences. One of the cDNAs was used for chromosomal in situ hybridization to localize the type VII collagen gene (COL7AI) within the human genome. §
MATERIALS AND METHODS
Immunoscreening ofa Keratinocyte cDNA Library in Agtl1. A human keratinocyte Agtll cDNA library (Clontech) containing 1.7 x 106 independent clones with an average insert size of 1.1 kilobases (kb) was subjected to immunoscreening with the purified IgG fraction of serum from a patient with epidermolysis bullosa acquisita (EBA) (14) .
The cDNA library was plated with Escherichia coli strain Y1090, and fusion-protein synthesis was induced with isopropyl ,8-D-thiogalactopyranoside-saturated nitrocellulose filters.
Positive recombinant clones were identified by antibody staining with a secondary antibody linked to alkaline phosphatase (ProtoBlot immunoscreening system, Promega), using standard procedures (15) .
Characterization of cDNAs. The isolated recombinant clones were plaque-purified, and the insert cDNAs were characterized by restriction enzyme digestions, dideoxynucleotide sequencing, polymerase chain reaction (PCR) amplification of corresponding sequences in mRNA, and North- (28) , and an Asn-Gly-Ser sequence (amino acids 295-297), a potential N-glycosylation site (29) . The segment ofthe sequence (amino acids 425-444) that has a high degree ofidentity with a previously published sequence of human type VII collagen (Table 1) is highlighted by stippling. The sequences of the synthetic PCR primers used for amplification of the segment spanning the junction ofthe collagenous and noncollagenous segments were as follows: 5' primer, 5'-TCTGGCCACAGCCCTGT-3' (nucleotides 1242-1258); 3' primer, 5'-TCACCCTTCATGGCTGGT-3' (reverse complement of nucleotides 1743-1760). ern blot analysis. Also, the identity of the largest cDNA, K-131, was confirmed by Western immunoblots reacted with antibodies that were selected with epitopes in the fusion protein synthesized by the recombinant K-131 clone (see below).
Nucleotide sequencing was done by the dideoxynucleotide chain termination method (16) . Amino acid sequences were deduced from the cDNA sequences with the PC/GENE program (IntelliGenetics). GenBank searches were performed using the FASTA program (17) .
RNA Isolation and Northern Blot Analysis. Human skin fibroblast cultures were established in our laboratory from skin biopsy specimens and maintained as described (18) . Normal human epidermal keratinocyte cultures established from surgical samples of adult skin were purchased from Clonetics (San Diego) and maintained as described (19) . WISH cells, a transformed amniotic epidermal cell line, were purchased from the Human Genetic Mutant Cell Repository (Camden, NJ) and maintained under culture conditions similar to those used for fibroblasts.
Total RNA was isolated from the cell cultures in early visual confluence by extraction with guanidinium isothiocyanate followed by cesium chloride density gradient centrifugation (20) . Northern analyses were performed with the K-131 cDNA isolated in this study, as well as with a 1.8-kb human proal(I) collagen cDNA (Hf-677) (21) and a 1.3-kb human fibronectin cDNA (Hf-771) (22) .
Western Immunoblot Analysis. Type VII collagen was extracted from human skin as described (14) . To and developed with a 4-chloro-1-naphthol reagent (Bio-Rad) in the presence of 30% hydrogen peroxide and methanol. Epitope Selection of Antibodies. To confirm the identity of the K-131 clone as a type VII collagen cDNA, epitope selection of antibodies with the EBA patient's serum was performed. The isolated K-131 recombinant clone was plated to confluence with E. coli Y1090 cells on a 150-mm agar plate. Fusion-protein synthesis was induced with isopropyl 8-Dthiogalactopyranoside-saturated nitrocellulose filters as indicated above. The filters were then incubated with 10 ml of the EBA patient's serum (diluted 1:20) and washed extensively, and the affinity-selected antibodies were isolated as described (25) .
Chromosomal in Situ Hybridization. For chromosomal assignment of the gene corresponding to the newly isolated K-131 cDNA, phytohemagglutinin-stimulated lymphocytes from normal adults were used to prepare metaphase chromosomes, and the chromosomal spreads were subjected to in situ hybridization (26, 27) .
RESULTS
Immunoscreening of a Keratinocyte Agtl1 cDNA Library. A human keratinocyte cDNA library in phage Agtll was screened with the IgG fraction purified from serum of a patient with EBA, an acquired disease characterized by the presence of circulating autoantibodies to type VII collagen (23) . Initial screening of -3 x 105 plaques yielded 8 positive clones, which were isolated and further characterized. The largest clone, K-131, was shown by agarose gel electrophoresis to be -1.9 kb in size.
Characterization of the K-131 cDNA. The K-131 cDNA was first subjected to dideoxynucleotide sequencing. The results indicated that the entire cDNA consisted of 1875 base pairs (bp) with an open reading frame encoding 625 amino acids (Fig. 1) . The 5' noncollagenous segment consisted of 439 amino acids, while the 3' sequences corresponded to a 186-amino acid collagenous domain. The collagenous segment of the deduced polypeptide was characterized by the presence of 52 Gly-Xaa-Yaa repeats, which were interrupted in several positions by insertions or deletions of 1 to 3 amino acids (Fig. 1) . Thus, part of the protein sequence deduced from nucleotide sequences of K-131 clearly corresponded to a collagenous polypeptide. GenBank searches of the nucleotide and amino acid data bases (April 1991) did not reveal a significant degree of similarity with known collagens or any other protein sequences. However, careful examination of the deduced amino acid sequences revealed a segment that had a high degree of identity with a published (9) peptide segment of human type VII collagen (Table 1 ). This amino acid sequence spanned the junction of a noncollagenous and a collagenous segment both at the protein level (9) and when deduced from the cDNA (Fig. 1) . Amino acid sequence Peptide* A (T) Q P R P E P G P V Y X E (K) G Q Q G E cDNAt T T Q P R P E P C P V C P K G O K " *Sequence was obtained by N-terminal analysis ofa protein fragment (P1) derived from human type VII collagen by limited pepsin proteolysis (9) . Parentheses signify ambiguity in the amino acid sequencing (the letter within parentheses was considered to be the most likely residue). X denotes a residue that was unidentified.
fSequence was deduced from the nucleotide sequence of K-131
cDNA (amino acids 425-444 in Fig. 1 ). Segments of complete identity are underlined.
To ensure that the collagenous and noncollagenous sequences were contiguous in the mRNAs that were used as templates for the initial synthesis of the cDNA library, PCR was performed with primers that allowed amplification of the sequences across the junction of the collagenous and noncollagenous segments (for the sequence of primers, see Fig. 1 ). The first strand cDNA was synthesized by reverse transcriptase using cultured human keratinocyte or WISH cell total RNA as templates. Examination of the PCR products demonstrated amplification of a segment of the expected size (542 bp), indicating that the cDNA sequence spanning thejunction of collagenous and noncollagenous segments is also present in mRNAs. Since both keratinocytes and WISH cells actively synthesize type VII collagen (6, 30, 31) , these observations further suggest that the K-131 cDNA corresponds to type VII collagen sequences.
Western Immunoblotting with Antibodies Selected with K-131 Fusion Protein. To further identify the K-131 cDNA as a type VII collagen clone, the fusion protein expressed by the K-131 clone was incubated with the same EBA patient's serum that was used for initial immunoscreening of the keratinocyte cDNA library. Unbound serum proteins were removed by extensive washings and the antibody bound to the fusion protein was eluted by acid extraction (25) . The antibody was then used for Western immunoblotting with type VII collagen from human skin with or without digestion with bacterial collagenase. Immunoblotting with the antibody eluted from the K-131 fusion protein complex recognized a distinct band of -290 kDa (Fig. 2) with antibodies eluted from the K-131 fusion protein identified a band of =145 kDa that was also recognized by EBA and L3D antibodies (Fig. 2 ). These observations collectively provide strong evidence that the K-131 cDNA encodes a polypeptide corresponding to human type VII collagen. Northern Analysis. To examine the cellular expression of the type VII collagen gene, total RNA was isolated from human epidermal keratinocytes and skin fibroblasts, two cell types that synthesize type VII collagen (30, 31) . Hybridization of the K-131 cDNA with total keratinocyte RNA (30 ,ug per lane) revealed a relatively strong signal to a single transcript, and a weaker signal to a transcript of the same size was detected with fibroblast RNA (Fig. 3) . Based on the relative mobilities of the 28S and 18S rRNAs (Fig. 3) and subsequent hybridizations of the same filter with human proal(I) collagen and fibronectin cDNAs, which identify 5.8-, 4.8-, and 8.0-kb mRNAs, respectively (21, 22) , the type VII collagen mRNA had an apparent size of :8.5 kb. ... Chromosomal in Situ Hybridization. To determine the chromosomal location of the type VII collagen gene (COL7AI) in the human genome, in situ hybridizations were performed with the K-131 cDNA. Analysis of 100 metaphase cells examined after in situ hybridizations revealed a total of 211 silver grains associated with chromosomes, and 78 of these grains (36.9%) were located on chromosome 3 (Fig. 4) . The distribution of grains on this chromosome was not random, but 74% of them mapped to the 3p21.1-p21.3 region, with a maximum concentration coinciding with the 3p21 band (Fig.  4) . These data map the human COL7AI to the short arm of chromosome 3.
DISCUSSION
We have isolated and characterized a human cDNA (K-131) that corresponds to type VII collagen. Type VII collagen had previously been characterized by ultrastructural and biochemical means, but only limited sequence information was available (9) . Previous studies have suggested that the collagenous central portion of the molecule is 4145 kDa in size and that the molecule contains a large, ==145-kDa noncollagenous domain that has been suggested to reside at the C-terminal end of the molecule (10, 11, 23) . Furthermore, the precursor polypeptide, the proal(VII) chain, has been suggested to contain an N-terminal domain (NC-2) with an estimated size of -30 kDa, but the tissue form of type VII collagen appears to lack this domain (23, 32) . Sequence information on the putative proal(VII) collagen chain, as deduced from nucleotide sequences of the K-131 cDNA, raises the possibility that the major noncollagenous domain recognized by the EBA serum is in fact in the N terminus. Specifically, the 5' noncollagenous segment deduced from the cDNA sequence indicates that this portion encodes 439 amino acids with a calculated molecular mass of :47 kDa. Since 47 kDa is clearly in excess of the =30-kDa proposed size of the N-terminal domain (NC-2), an alternative possibility is that the newly synthesized proal(VII) collagen 16- Northern hybridizations of human keratinocyte and skin fibroblast RNA with the K-131 cDNA recognized a single mRNA transcript of -8.5 kb. The abundance of this mRNA was considerably higher in keratinocytes than in skin fibroblasts when equal amounts of total RNA were analyzed (Fig.  3) . This observation is consistent with previous demonstrations that keratinocytes are the primary source of type VII collagen in human skin and that cultured keratinocytes synthesize significantly higher amounts of type VII collagen protein than do skin fibroblast cultures (33) . The type VII collagen mRNA (-8.5 kb) could maximally encode a putative polypeptide of -2800 amino acids with an estimated molecular mass of -280 kDa. This is somewhat smaller than the estimated sizes of the proal(VII) collagen chains, which vary from 300 to 350 kDa (8) . This difference could be explained by posttranslational modification of the peptides (see Fig. 1 ).
The collagenous segment encoded by the K-131 cDNA revealed the presence of 52 Gly-Xaa-Yaa repeats, which were interrupted in several positions. The presence ofan imperfect collagenous segment is consistent with previous demonstrations of susceptibility of the collagenous domain of type VII collagen to pepsin proteolysis (9) . Limited sequence information has been published on the N-terminal sequences of the cleavage products of type VII collagen isolated after digestions with pepsin, interstitial collagenase, or type IV collagenase (gelatinase) (9) . Comparison ofthe sequence data deduced from the K-131 cDNA with the sequence described by Seltzer et al. (9) revealed a segment that corresponded to the N-terminal sequence of a pepsin cleavage product of human type VII collagen (Table 1) . Specifically, 15 amino acids deduced from a segment of nucleotide sequences in the K-131 cDNA were identical to the corresponding amino acid residues in the published sequence, and both sequences spanned the junction of noncollagenous and collagenous segments. In addition, a cysteine residue was identified in the position that was not assigned by the amino acid sequencing. Four of the remaining amino acids in the two sequences differed, but the reasons for this discrepancy are not clear. Nevertheless, the high degree of identity and the precise match of a 7-amino acid sequence (Thr-Gln-Pro-Arg-Pro-GluPro) clearly identify the clone K-131 as a type VII collagen cDNA.
The K-131 cDNA was used in chromosomal in situ hybridizations to localize the corresponding gene to chromosome 3. Collagen genes are widely dispersed within the human genome (3). Only one of the genes coding for an a chain has been previously mapped to chromosome 3. Specifically, the human al(VIII) collagen gene has been shown to reside in the long arm of chromosome 3 (34) . Localization of COL7A1 to the locus 3p21 in the short arm of chromosome 3 clearly indicates that this cDNA corresponds to a previously undescribed collagenous gene.
